Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00374
|
|||||
| Drug Name |
Amino acids
|
|||||
| Synonyms |
Aminess 5.2% Essential Amino Acids W/ Histadine; Amino Acids; Aminosyn 10%; Aminosyn 10% (Ph6); Aminosyn 3.5%; Aminosyn 3.5% In Plastic Container; Aminosyn 5%; Aminosyn 7%; Aminosyn 7% (Ph6); Aminosyn 8.5%; Aminosyn 8.5% (Ph6); Aminosyn Ii 10%; Aminosyn Ii 10% In Plastic Container; Aminosyn Ii 15% In Plastic Container; Aminosyn Ii 3.5%; Aminosyn Ii 3.5% In Plastic Container; Aminosyn Ii 5%; Aminosyn Ii 7%; Aminosyn Ii 8.5%; Aminosyn-hbc 7%; Aminosyn-hbc 7% In Plastic Container; Aminosyn-hf 8%; Aminosyn-pf 10%; Aminosyn-pf 7%; Aminosyn-rf 5.2%; Branchamin 4%; Branchamin 4% In Plastic Container; Clinisol 15% Sulfite Free In Plastic Container; Freamine 8.5%; Freamine Hbc 6.9%; Freamine Ii 8.5%; Freamine Iii 10%; Freamine Iii 8.5%; Hepatamine 8%; Hepatasol 8%; Neopham 6.4%; Nephramine 5.4%; Novamine 11.4%; Novamine 15%; Novamine 15% Sulfite Free In Plastic Container; Novamine 8.5%; Premasol 10% In Plastic Container; Premasol 6% In Plastic Container; Prosol 20% Sulfite Free In Plastic Container; Renamin W/O Electrolytes; Travasol 10% In Plastic Container; Travasol 10% W/O Electrolytes; Travasol 5.5% In Plastic Container; Travasol 5.5% W/O Electrolytes; Travasol 8.5% In Plastic Container; Travasol 8.5% W/O Electrolytes; Trophamine; Trophamine 10%
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Nutritional deficiency [ICD11: 5B7Z] | Approved | [1] | |||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ASC1 | Transporter Info | Asc-type amino acid transporter 1 | Substrate | [2] | |
| ATB0 | Transporter Info | Amino acid transporter ATB0+ | Substrate | [3] | ||
| B0AT1 | Transporter Info | Sodium-dependent neutral amino acid transporter B(0)AT1 | Substrate | [4] | ||
| B0AT3 | Transporter Info | Sodium-dependent neutral amino acid transporter B(0)AT3 | Substrate | [5] | ||
| CAT1 | Transporter Info | High affinity cationic amino acid transporter 1 | Substrate | [6] | ||
| CAT3 | Transporter Info | Cationic amino acid transporter 3 | Substrate | [7] | ||
| NBAT | Transporter Info | Neutral and basic amino acid transport protein rBAT | Substrate | [8] | ||
| NTT4 | Transporter Info | Sodium-dependent neurotransmitter transporter | Substrate | [9] | ||
| PAT1 | Transporter Info | Proton-coupled amino acid transporter 1 | Substrate | [10] | ||
| PAT3 | Transporter Info | Proton-coupled amino acid transporter 3 | Substrate | [11] | ||
| SIT1 | Transporter Info | Sodium/imino-acid transporter 1 | Substrate | [12] | ||
| SLC38A11 | Transporter Info | Putative sodium-coupled neutral amino acid transporter 11 | Substrate | [13] | ||
| SLC7A6 | Transporter Info | Y+L amino acid transporter 2 | Substrate | [14] | ||
| SNAT6 | Transporter Info | Probable sodium-coupled neutral amino acid transporter 6 | Substrate | [15] | ||
| References | ||||||
| 1 | L-glutamic acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | The ABCs of membrane transporters in health and disease (SLC series): Introduction. Molecular Aspects of Medicine, 2013, 34(2-3):95-107. (GeneName=SLC7A10) | |||||
| 3 | Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer. Br J Pharmacol. 2016 Dec;173(23):3292-3306. | |||||
| 4 | Amino acid transporters in the regulation of insulin secretion and signalling. Biochem Soc Trans. 2019 Apr 30;47(2):571-590. | |||||
| 5 | Spatial mRNA Expression and Response to Fasting and Refeeding of Neutral Amino Acid Transporters slc6a18 and slc6a19a in the Intestinal Epithelium of Mozambique tilapia. Front Physiol. 2018 Mar 13;9:212. | |||||
| 6 | The ABCs of membrane transporters in health and disease (SLC series): Introduction. Molecular Aspects of Medicine, 2013, 34(2-3):95-107. (GeneName=SLC7A1) | |||||
| 7 | Hypomorphic variants of cationic amino acid transporter 3 in males with autism spectrum disorders. Amino Acids. 2015 Dec;47(12):2647-58. | |||||
| 8 | Channels, transporters and receptors for cadmium and cadmium complexes in eukaryotic cells: myths and facts. Biometals. 2019 Jan 30. | |||||
| 9 | Identification and functional characterization of solute carrier family 6 genes in Ciona savignyi. Gene. 2019 Apr 23;705:142-148. | |||||
| 10 | Substrate specificity of the amino acid transporter PAT1. Amino Acids. 2006 Sep;31(2):111-7. | |||||
| 11 | Organization and expression of the SLC36 cluster of amino acid transporter genes. Mamm Genome. 2004 Feb;15(2):114-25. | |||||
| 12 | The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2). Biochem J. 2006 Jan 1;393(Pt 1):421-30. | |||||
| 13 | Nutritional Stress Induced by Amino Acid Starvation Results in Changes for Slc38 Transporters in Immortalized Hypothalamic Neuronal Cells and Primary Cortex Cells. Front Mol Biosci. 2018 May 8;5:45. | |||||
| 14 | The ABCs of membrane transporters in health and disease (SLC series): Introduction. Molecular Aspects of Medicine, 2013, 34(2-3):95-107. (GeneName=SLC7A6) | |||||
| 15 | Histological analysis of SLC38A6 (SNAT6) expression in mouse brain shows selective expression in excitatory neurons with high expression in the synapses. PLoS One. 2014 Apr 21;9(4):e95438. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.